ABSTRACT
The Department of Medical Research (DMR) has been producing a safe and effective plasma derived hepatitis B (HB) vaccine since 1997 to meet the criteria of quality control tests recommended by the WHO. The production of this HBvaccine requires the HBs antigen (Ag) pasitive blood as raw material which has been collected from blood banks of the various hospitals in Yangon area. Among these collected blood bottles, only those with high HBsAg titre were pooled and purified for further manufacturing process. In this study, HBsAg titre of the blood bottles collected during the year 1992, 1993,1999 and 2000, and those used for production of various batches of HB vaccine were determined and compared. It was found that the quantities of blood bottles available for HB vaccine production and their HBsAg titres have been apparently reduced in the last two years. This may affect the production capacity of the vaccine. This could be one of the major obstacles ofr the large scale production of the plasma-derived HB vaccine tho meet the requirement of Extended Program of Immumization (EPI) in the near future. To fulfil this requirement, several solutions have been considered and discussed in this study.
Subject(s)
Hepatitis B VaccinesABSTRACT
The stability of the DMR hepatitis B vaccine at 4C and room temperature has been followed over a period of one year by monitoring its physical, chemical and biological characteristics bimonthly starting from February 1996. The pH and protein content of the vaccine did not change for both storage conditions throughout the study. The vaccines were found to be sterile and free from pyrogens and passed the general safety test on mice. The HBsAg titer started to decline after eight months of storage at 4C and after 10 days of storage at room temperature. However, the HBsAg adsorption rate to the adjuvant remained over 95 per cent for both storage conditions.
Subject(s)
Viral Hepatitis Vaccines , MyanmarABSTRACT
One hundred and eleven adult patients who attended North Okkalapa General Hospital for uncomplicated falciparum malaria were chosen for the study. They were treated with dihydroartemisinine (Cetexin), quinine, artesunate tablets and artemether injection. Fifty nine adult male and female without malaria were chosen as controls. They were treated with sulfadoxine-pyrimethamine, quinine and artesunate. Thick and thin blood films were taken from the patients daily and were stained and counted for malaria parasites. Packed cell volume (PCV), WBC count and reticulocyte count were also done. Among the patients treated with drugs, there was a significant fall in the mean reticulocyte count (number concentration and number fraction) at day 3. But the reticulocytes were raised back to normal at days 7 and 14. There was no significant changes in the mean packed cell volume (PCV) and mean level of total WBC count of the patients in all 4 groups. Among normal controls treated with artesunate tablets, there was also a significant fall in the mean reticulocyte count at day 3 but the mean reticulocytes count was also raised back to normal at days 7 and 14. Among normal controls treated with quinine and sulfadoxine-pyrimethamine tablets, there was no significant fall in the mean reticulocyte count. And there was no significant changes in PCV and WBC count in all 3 groups of controls. The fall in reticulocyte counts can be due to part of the disease malaria as well as to the drug including quinine and not singly to artemisinine therapy alone.
Subject(s)
Antimalarials , Malaria, FalciparumABSTRACT
Six hundred and ninety samples of raw meat collected from the slaughter house and markets of Rangoon were tested at the Bacteriology Section and Food and Drug Section of National Health Laboratory from June 1973 to July 1974. 63 salmonella of 9 different serotypes were isolated. Out of which S.anatum and S. derby are found to be the most frequent serotype all three kinds of raw meat. This is the first time salmonella from raw meat is reported.